KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Repurchased Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Biolife Solutions (BLFS) Deferred Taxes (2020 - 2025)

Biolife Solutions (BLFS) has disclosed Deferred Taxes for 6 consecutive years, with $14000.0 as the latest value for Q3 2025.

Quarterly Deferred Taxes rose 115.05% to $14000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $65000.0 through Dec 2025, up 201.56% year-over-year, with the annual reading at $65000.0 for FY2025, 201.56% up from the prior year.
Deferred Taxes for Q3 2025 was $14000.0 at Biolife Solutions, down from $45000.0 in the prior quarter.
The five-year high for Deferred Taxes was $45000.0 in Q2 2025, with the low at -$12.6 million in Q2 2021.
Average Deferred Taxes over 5 years is -$1.6 million, with a median of -$95500.0 recorded in 2023.
Peak annual rise in Deferred Taxes hit 124.49% in 2024, while the deepest fall reached 504.35% in 2024.
Over 5 years, Deferred Taxes stood at -$2.6 million in 2021, then soared by 88.36% to -$301000.0 in 2022, then skyrocketed by 67.44% to -$98000.0 in 2023, then soared by 124.49% to $24000.0 in 2024, then plummeted by 41.67% to $14000.0 in 2025.
According to Business Quant data, Deferred Taxes over the past three periods came in at $14000.0, $45000.0, and $6000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.